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Abstract
Background: The staged laparotomy in the operative management of emergency general surgery (EGS) patients is
an extension of trauma surgeons operating on this population. Indications for its application, however, are not well
defined, and are currently based on the lethal triad used in physiologically-decompensated trauma patients. This
study sought to determine the acute indications for the staged, rapid source control laparotomy (RSCL) in EGS
patients.
Methods: All EGS patients undergoing emergent staged RSCL and non-RSCL over 3 years were studied.
Demographics, physiologic parameters, perioperative variables, outcomes, and survival were compared. Logistic
regression models determined the influence of physiologic parameters on mortality and postoperative
complications. EGS-RSCL indications were defined.
Results: 215 EGS patients underwent emergent laparotomy; 53 (25 %) were staged RSCL. In the 53 patients who
underwent a staged RSCL based on the lethal triad, adjusted multivariable regression analysis shows that when used
alone, no component of the lethal triad independently improved survival. Staged RSCL may decrease mortality in
patients with preoperative severe sepsis / septic shock, and an elevated lactate (≥3); acidosis (pH≤ 7.25); elderly (≥70);
male gender; and multiple comorbidities (≥3). Of the 162 non-RSCL emergent laparotomies, 27 (17 %) required
unplanned re-explorations; of these, 17 (63 %) had sepsis preoperatively and 9 (33 %) died.
Conclusions: The acute physiologic indicators that help guide operative decisions in trauma may not confer a similar
survival advantage in EGS. To replace the lethal triad, criteria for application of the staged RSCL in EGS need to be
defined. Based on these results, the indications should include severe sepsis / septic shock, lactate, acidosis, gender,
age, and pre-existing comorbidities. When correctly applied, the staged RSCL may help to improve survival in
decompensated EGS patients.
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Background
The staged laparotomy in the operative management of
select trauma patients is designed to ensure their immedi-
ate survival [1–6]. The damage control (DC) laparotomy
is therefore not an operation of last resort; rather, it is a
well thought-out stage on a continuum of care which pri-
oritizes the restoration of physiologic normality and
homeostasis above definitive organ repair and anatomic
reconstruction.
Application of DC principles are based on the clin-
ical recognition of a trauma patient who is physiolo-
gically decompensated as defined by the lethal triad
seen with hemorrhagic shock: acidosis, coagulopathy,
and hypothermia. Decompensated trauma patients
must be rescued to avoid progression to irreversible
physiologic exhaustion and death; abbreviated opera-
tions allow stabilization, correction, and reevaluation
of physiologic derangements in an intensive care unit
setting [6–13].
Similarly, a select group of emergency general surgery
(EGS) patients also present decompensated, near irrevers-
ible physiologic exhaustion and death, but for different
reasons, often driven by severe sepsis or septic shock [14].
As a natural extension of trauma surgeons operating on
the EGS patient-population, DC principles have been
widely applied to the operative management of EGS
patients.
Indications for DC application in EGS patients, how-
ever, are not well defined, and are currently based on the
lethal triad used in trauma patients. Because the lethal
triad in trauma is founded on patients presenting with
hemorrhagic shock – something less commonly seen in
EGS patients – its use to guide operative decision mak-
ing in EGS patients may not be appropriate.
This study sought to determine the acute physiologic
indications for the staged, rapid source control laparot-
omy (RSCL) in EGS patients. Our hypothesis was that
application of the lethal triad to EGS patients as criteria
for implementation of abbreviated laparotomy would
not improve outcomes, and that the definition of a
physiologically decompensated EGS patient would be
unique from that used in trauma patients.
Methods
This is a retrospective review of consecutive EGS pa-
tients undergoing emergent, non-trauma related lapar-
otomies over 3 years, from March 1, 2007 to March 1,
2010, at a tertiary medical center. Emergent operations
were defined in accordance with the National Surgical
Quality Improvement Program’s (NSQIP) definition of
an emergency case: one performed as soon as possible
and no later than 12 h after the patient has been admit-
ted to the hospital or after the onset of related preopera-
tive symptomatology [15].
Variables were collected through electronic chart review.
Data included demographics, physiologic parameters,
perioperative variables, outcomes, and survival. Magni-
tude of the inflammatory response (four categories: no in-
flammation, SIRS, sepsis, or severe sepsis/septic shock)
was classified based on the NSQIP definition; this defin-
ition is in concert with standardized definitions outlined
by the American College of Chest Physicians (ACCP), the
Society of Critical Care Medicine (SCCM), and the Surgi-
cal Infection Society (SIS) [16].
Patients were identified as undergoing a rapid source
control laparotomy (RSCL; i.e., damage control laparot-
omy; planned re-laparotomy) if there was a deliberate,
preemptive plan to perform an immediate, limited, staged
operation as part of an ongoing continuum of resuscita-
tion. The decision to proceed with staged RSCL was based
on the lethal triad used in trauma patients; such RSCL in-
tentions were identified in the operative note, which had
to address the planned attempt to reverse the pre-
terminal effects of pre-operative physiologic derange-
ments, and/or intra-abdominal hypertension, by means of
an abbreviated laparotomy. These patients were left with
an open abdomen with a negative pressure dressing at the
end of the initial operation, and transferred to the inten-
sive care unit for stabilization. The second operation was
then governed by a planned re-laparotomy, once resusci-
tation and stabilization had been achieved.
Non-RSCL patients were those who underwent non-
staged operations, and had their fascia closed at the
completion of the initial operation. If these patients sub-
sequently required a re-laparotomy, this would be con-
sidered an unplanned re-laparotomy, or an “on-demand
re-laparotomy” [17, 18]. For the current analyses, only
patients who underwent open operations with colon or
small bowel resections were included, based on their
high degree of postoperative morbidity and mortality,
comparable source for sepsis, and the increased power
of the analyses [19–21].
Patient characteristics, physiologic parameters, peri-
operative variables, outcome metrics, and survival were
first compared using univariate techniques. Chi-squared
analysis (χ2) or Fisher’s exact test were used to compare
differences in proportions of categorical variables; such
data were summarized by percentages. Student’s t-tests
were used to compare normally distributed continuous
variables; such data were summarized by mean values
with standard deviations (±SD). Wilcoxon rank sum
tests were used to compare non-normally distributed
continuous variables; such data were summarized by
median values with interquartile ranges.
In hospital mortality was the primary outcome meas-
ure. Logistic regression models determined the influence
of acute physiologic parameters and other patient char-
acteristics on in-hospital mortality; analyses assessing
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determinants of postoperative complications were
additionally completed. All candidate covariates for mul-
tivariable regression were included in a full selection
model; variables were not excluded based on their statis-
tical significance. Significance was defined as p-value <
0.05 throughout. EGS-based RSCL indications were
defined.
All statistical analyses were conducting using a
commercially available statistics software program
(SAS 9.2; SAS Institute Inc., Cary, NC). Approval was
obtained from the Wake Forest University Baptist
Medical Center Institutional Review Board.
Results
215 EGS patients underwent emergent laparotomy dur-
ing the study period, 162 (75 %) were non-rapid source
control laparotomy (non-RSCL) operations and 53
(25 %) were staged rapid source control laparotomy
(RSCL; damage control; planned re-laparotomy). Com-
paring the two operative groups, there were no significant
differences in patient characteristics, including gender, race,
age, or comorbidities (Table 1).
Peri-operative physiologic scores and metrics, how-
ever, did significantly differ (Table 1). Compared with
emergent patients in the RSCL cohort, the non-RSCL
group was overall healthier, with a significantly higher
percentage of patients with no preoperative inflamma-
tion and with lower ASA scores (1, 2, or 3). The two
groups did not differ significantly with regard to pa-
tients with severe sepsis / septic shock, hypothermia,
coagulopathy, or acidosis. No patients in either group
fit only into the SIRS only classification of preopera-
tive inflammation, indicating that all had a presumed
source of infection.
Table 1 Patient characteristics and peri-operative physiologic scores & metrics, by operation type
Variablea non-RSCL (n = 162) RSCL (n = 53) p-valueb
Male gender 94 (58.0 %) 29 (54.7 %) 0.6727
Race & Ethnicity:
White 128 (79.0 %) 46 (86.8 %) 0.2107
Black 27 (16.7 %) 6 (11.2 %) 0.3486
Age, years 61 (17) 64 (13) 0.2336
Age (≥70) 55 (34.0 %) 19 (35.9 %) 0.8006
Comorbidities:
Number comorbidities, average 1.9 (2.2) 2.2 (2.8) 0.4641
No comorbidities 71 (43.8 %) 23 (43.4 %) 0.9562
1 comorbidity 19 (11.7 %) 2 (3.8 %) 0.0904
2 comorbidities 14 (8.6 %) 7 (13.2 %) 0.3311
≥3 comorbidities 58 (35.8 %) 21 (39.6 %) 0.6166
Inflammatory status preoperatively:
No inflammation 75 (46.3 %) 10 (18.9 %) 0.0004
Sepsis 59 (36.4 %) 28 (52.8 %) 0.0346
Severe sepsis/septic shock 28 (17.3 %) 15 (28.3 %) 0.0817
Lethal Triad:
Hypothermia (temp≤ 35C) 24 (16.8 %) 7 (14.9 %) 0.7610
Coagulopathy (INR ≥ 1.7) 13 (11.1 %) 9 (18.4 %) 0.2085
Acidosis (pH≤ 7.25) 24 (22.2 %) 18 (35.3 %) 0.0810
Patient characteristics:
ASA score, average 3 (1) 4 (1) <0.0001
ASA score, 1 or 2 23 (14.2 %) 0 (0.0 %) 0.0015
ASA score, 3 65 (40.1 %) 8 (15.1 %) 0.0008
ASA score, 4 or 5 74 (45.7 %) 45 (84.9 %) <0.0001
Lactate (≥3) 32 (33.3 %) 26 (51.0 %) 0.0372
RSCL rapid source control laparotomy, PRBC packed red blood cells, C Celsius, INR international normalized ratio, ASA American Society of Anesthesiologists, L liters
aCategorical variables are presented as number (%); continuous data are presented as mean (± standard deviation); and non-normally distributed continuous
variables as median (interquartile range)
bP-values for overall tests of differences between the groups from χ2 or Fisher’s Exact Test for categorical variables and one-way analysis of variance or Kruskal-
Wallis test for continuous variables; p-value of <0.05 significant
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Overall mortality in the RSCL group was significantly
higher than in the non-RSCL population (45 % vs 20 %)
(Table 2). Specifically, mortality was higher in RSCL com-
pared to non-RSCL patients who were female, white, and
without comorbidities. Interestingly, however, mortality
between the two operative approaches was no different for
patients with sepsis or severe sepsis / septic shock; males;
elderly (age ≥70); patients with multiple comorbidities
(≥3); patients with hypothermia (temperature ≤35C), co-
agulopathy (INR ≥1.7), and acidosis (pH ≤ 7.25) (the lethal
triad criteria); for all ASA scoring levels; and for elevated
lactate levels.
The application of the lethal triad to guide the use
of RSCL did not discriminate between survivors and
non-survivors in our multivariable logistic regression
models (Table 3). Patients with hypothermia, coagu-
lopathy, and acidosis who underwent damage control
procedures had similar rates of mortality compared
with the non-RSCL group.
In emergent operative patients undergoing non-RSCL
(Table 4), multiple variables increased the chances of
mortality in the univariate analyses, including severe
sepsis/septic shock, male gender, elderly, acidosis, ele-
vated lactate, and ASA score of 4 or 5. Two variables in
this group portended an increased likelihood of survival:
patients without inflammation and those with an ASA
score of 3. The adjusted multivariable logistic regression
model confirmed that four variables significantly and
independently increased the chances of mortality for
non-RSCL operations: patients with severe sepsis / septic
shock, male gender, elderly, and acidosis.
In contrast to the non-RSCL group, there were no var-
iables in the unadjusted univariate analyses for the RSCL
cohort (Table 5) that increased the odds of mortality. In
the adjusted multivariable regression, patients had sig-
nificantly improved chances of survival when undergoing
RSCL with two existing factors: elevated preoperative
lactate levels or multiple comorbidities. Patients with
Table 2 Rates of in-hospital mortality for patient characteristics and peri-operative physiologic metrics, by operation type
Variablea non-RSCL (n = 162) RSCL (n = 53) p-valueb
All patients: 33 (20.4 %) 24 (45.3 %) 0.0004
Inflammatory status preoperatively:
No inflammation 8 (10.7 %) 5 (50.0 %) 0.0012
Sepsis 10 (19.9 %) 10 (35.7 %) 0.0520
Severe sepsis/septic shock 15 (53.6 %) 9 (60.0 %) 0.6858
Patient Characteristics:
Male Gender 25 (26.6 %) 13 (44.8 %) 0.0632
Female Gender 8 (11.7 %) 11 (45.8 %) 0.0004
Race, White 27 (21.1 %) 20 (43.5 %) 0.0034
Age (≥70) 20 (36.4 %) 10 (52.6 %) 0.2131
No comorbidities 17 (23.9 %) 11 (47.8 %) 0.0295
1 comorbidity 0 (0.0 %) 1 (50.0 %) 0.0016
2 comorbidities 3 (21.4 %) 3 (42.9 %) 0.3055
≥3 comorbidities 13 (22.4 %) 9 (42.9 %) 0.0733
Lethal Triad:
Hypothermia (temp≤ 35C) 8 (33.3 %) 3 (42.9 %) 0.6431
Coagulopathy (INR ≥ 1.7) 5 (38.5 %) 5 (55.6 %) 0.4285
Acidosis (pH≤ 7.25) 12 (50.0 %) 10 (55.6 %) 0.7213
Patient characteristics:
ASA score, 1 or 2 0 (0.0 %) 0 (0.0 %) -
ASA score, 3 5 (7.7 %) 1 (12.5 %) 0.6404
ASA score, 4 or 5 28 (37.8 %) 23 (51.1 %) 0.1559
Lactate (≥3) 13 (40.6 %) 11 (42.3 %) 0.8970
RSCL rapid source control laparotomy, PRBC packed red blood cells, C Celsius, INR international normalized ratio, ASA American Society of Anesthesiologists, L liters
aCategorical variables are presented as number (%); continuous data are presented as mean (± standard deviation); and non-normally distributed continuous
variables as median (interquartile range)
bP-values for overall tests of differences between the groups from χ2 or Fisher’s Exact Test for categorical variables and one-way analysis of variance or Kruskal-
Wallis test for continuous variables; p-value of <0.05 significant
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preoperative acidosis had significant increased risk of
death with RSCL, just as in the non-RSCL group.
Of the 162 non-RSCL emergent laparotomies, 27
(17 %) required unplanned re-explorations. Mortality in
this unplanned take-back group was significantly higher
than in the patients who did not require re-exploration
(33.3 % vs 17.8 %; p = 0.04). Of the 33 deaths in the non-
RSCL cohort, 27.3 % were patients necessitating
unplanned re-explorations. Compared to the non-RSCL
patients who did not undergo re-exploration, the un-
planned take-back group had significantly higher rates of
pre-operative severe sepsis / septic shock (44.4 % vs
11.9 %; p < 0.0001). Of all severe sepsis / septic shock
patients in the non-RSCL group, 42.9 % (12) required
re-exploration (p < 0.0001).
Discussion
The negative downstream consequences of inflammation
are well established in acute care surgery. In the trauma
patient population, severe physiologic derangements,
particularly the lethal triad (hypothermia, acidosis, and co-
agulopathy), guide management decisions [22]. Research
into these postinjury systemic inflammatory states has
established the importance, for example, of the damage
Table 3 Logistic regression analyses predicting in-hospital mortality for RSCL patients, based only on the lethal triad
Variablea Unadjusted modela Adjusted multivariable modelb
OR (95 % CI) p-valuec OR (95 % CI) p-valuec
Lethal Triad:
Hypothermia (temp≤ 35C) 0.83 (0.16–4.19) 0.8205 0.70 (0.13–3.74) 0.5330
Coagulopathy (INR ≥ 1.7) 1.53 (0.36–6.55) 0.5680 1.52 (0.34–6.87) 0.5884
Acidosis (pH≤ 7.25) 1.92 (0.60–6.15) 0.2703 1.70 (0.47–6.09) 0.4167
RSCL rapid source control laparotomy, C Celsius, INR international normalized ratio
aUnadjusted univariate analyses were used to test an independent variables’s predictive ability on in-hospital mortality
bModel covariates for mortality were chosen by full selection
cP-value of <0.05 significant
Table 4 Logistic regression analyses predicting in-hospital mortality for non-RSCL patients
Variablea Unadjusted modela Adjusted multivariable modelb
OR (95 % CI) p-valuec OR (95 % CI) p-valuec
Preoperative inflammatory status:
No inflammation 0.30 (0.12–0.71) 0.0060 1.00 -
Sepsis 0.71 (0.31–1.62) 0.4146 0.18 (0.02–1.95) 0.1583
Severe sepsis/septic shock 7.44 (3.04–18.17) <0.0001 12.32 (1.19–127.33) 0.0350
Patient Characteristics:
Male Gender 2.72 (1.14–6.47) 0.0240 23.98 (2.00–287.34) 0.0122
Race, White 1.25 (0.47–3.32) 0.6579 0.25 (0.01–5.64) 0.3857
Age (≥70) 4.13 (1.86–9.19) 0.0005 13.77 (1.30–145.70) 0.0293
No comorbidities 1.48 (0.69–3.18) 0.3201 1.00 -
1 comorbidity 0.001 (0.001–999.99) 0.9546 0.001 (0.001–999.99) 0.9132
2 comorbidities 1.07 (0.284.09) 0.9181 0.04 (0.01–4.13) 0.1746
≥3 comorbidities 1.21 (0.55–2.66) 0.6299 0.07 (0.01–0.57) 0.0139
Preoperative metrics:
Acidosis (pH≤ 7.25) 3.94 (1.51–10.30) 0.0052 11.08 (1.02–120.64) 0.0484
Lactate (≥3) 2.68 (1.06–6.82) 0.0378 0.62 (0.08–4.78) 0.6425
Coagulopathy (INR ≥ 1.7) 2.08 (0.62–6.97) 0.2333 2.11 (0.22–20.43) 0.5183
ASA score, 1 or 2 0.001 (0.001–999.99) 0.9672 1.00 -
ASA score, 3 0.21 (0.08–0.57) 0.0022 999 (0.001–999.99) 0.9574
ASA score, 4 or 5 10.10 (3.65–27.95) <0.0001 999 (0.001–999.99) 0.9416
RSCL rapid source control laparotomy, PRBC packed red blood cells, C Celsius, INR international normalized ratio, ASA American Society of Anesthesiologists
aUnadjusted univariate analyses were used to test an independent variables’s predictive ability on in-hospital mortality
bModel covariates for mortality were chosen by full selection
cP-value of <0.05 significant
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control (DC) laparotomy for early definitive source control
[1–6], and more recently the concept of DC resuscitation
[23]. In critically ill patients, the substantial benefits of
blunting the proinflammatory immune response has led to
such key practices as early goal-directed therapy [24] and
standardized treatment protocols for sepsis [25–27].
In EGS patients, upregulation of the systemic inflamma-
tory response leads to a cascade of physiologic insults, and
is a prime contributor to death, with mortality rates for se-
vere sepsis / septic shock of over 40 % [14, 19]. However,
unlike in trauma and critically ill patients, where
physiologic derangements are aggressively acted on
with specific corrective interventions, in EGS patients
similar preoperative derangements are often recog-
nized but may not be targeted with explicit restora-
tive management techniques [28].
One solution to mitigating the negative downstream
effects of physiologic insults seen preoperatively in EGS
patients has been the application of DC techniques. Akin
to the DC concept in trauma, it has been theorized that
EGS patients needing operative intervention may benefit
from an abbreviated laparotomy (i.e. rapid source con-
trol laparotomy; RSCL) with planned take-back. Such an
operation is one of the first stages on a continuum of
care that prioritizes the restoration of physiologic nor-
mality and homeostasis, and deemphasizes the import-
ance of immediate organ repair and definitive anatomic
reconstruction.
To guide the use of the staged RSCL in EGS patients,
trauma’s lethal triad has been applied as the standard cri-
teria for operative decision-making. The data to support
this, however, is limited [29]. Furthermore, “expert opin-
ion” about the timing of nontraumatic surgical emergen-
cies has been published to guide surgical interventions in
EGS patients [30]. To date, no data or empirical evidence
has specifically defined a unique set of criteria on which to
base the use of RSCL techniques to improve the poor sur-
vival rates of physiologically decompensated EGS patients.
Our results represent such data, and suggest that the
acute physiologic indicators which help guide operative
decisions in trauma patients may not confer a similar
survival advantage to decompensated EGS patients
undergoing an emergent laparotomy. In the 53 patients
who underwent a staged RSCL based on the lethal triad,
adjusted multivariable regression analysis shows that
when used alone, no component of the lethal triad inde-
pendently improved survival (Table 3). Therefore, con-
trary to current practices, application of the lethal triad
Table 5 Logistic regression analyses predicting in-hospital mortality for RSCL patients
Variablea Unadjusted modela Adjusted multivariable modelb
OR (95 % CI) p-valuec OR (95 % CI) p-valuec
Preoperative inflammatory status:
No inflammation 1.26 (0.32–5.01) 0.7397 1.00 -
Sepsis 0.44 (0.15–1.32) 0.1415 0.60 (0.07–5.39) 0.6446
Severe sepsis/septic shock 2.30 (0.68–7.80) 0.1811 3.29 (0.26–41.92) 0.3596
Patient Characteristics:
Male Gender 0.96 (0.32–2.85) 0.9416 0.55 (0.07–4.28) 0.5708
Race, White 0.58 (0.12–2.88) 0.5022 0.26 (0.01–8.47) 0.4509
Age (≥70) 1.59 (0.51–4.92) 0.4230 5.19 (0.75–35.74) 0.0942
No comorbidities 1.20 (0.40–3.57) 0.7448 1.00 -
1 comorbidity 1.22 (0.07–20.55) 0.8915 999 (0.001–999.99) 0.9848
2 comorbidities 0.89 (0.18–4.45) 0.8900 0.58 (0.05–6.08) 0.6458
≥3 comorbidities 0.85 (0.28–2.58) 0.7739 0.06 (0.01–0.70) 0.0252
Preoperative metrics:
Acidosis (pH≤ 7.25) 1.92 (0.60–6.15) 0.2703 19.42 (1.74–216.65) 0.0159
Lactate (≥3) 0.79 (0.26–2.40) 0.6831 0.10 (0.01–0.93) 0.0431
Coagulopathy (INR ≥ 1.7) 1.53 (0.36–6.55) 0.5680 2.14 (0.27–16.83) 0.4682
ASA score, 1 or 2 - - 1.00 -
ASA score, 3 0.14 (0.02–1.20) 0.0729 1.00 -
ASA score, 4 or 5 7.32 (0.83–64.43) 0.0729 26.45 (0.82–857.50) 0.0650
RSCL rapid source control laparotomy, PRBC packed red blood cells, C Celsius, INR international normalized ratio, ASA American Society of Anesthesiologists
aUnadjusted univariate analyses were used to test an independent variables’s predictive ability on in-hospital mortality
bModel covariates for mortality were chosen by full selection
cP-value of <0.05 significant
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does not appear to improve survival rates in EGS pa-
tients, and may possibly lead to overuse of RSCL with
higher mortality rates (Table 2).
These data also illustrate that the indications for per-
forming a staged RSCL in EGS patients should be founded
on a set of unique preoperative physiologic parameters,
coupled with inherent patient traits, which collectively
define an EGS patient as physiologically decompensated
(Tables 4 & 5). Our results suggest a profile of a patient
who may realize a survival benefit from a RSCL: a patient
with preoperative severe sepsis / septic shock, with an ele-
vated lactate (≥3); acidosis (pH ≤ 7.25); elderly (≥70); male
gender; and multiple comorbidities (≥3).
Patients with severe sepsis / septic shock had equally
high unadjusted mortality rates in both cohorts: 53.6 %
in the non-RSCL group and 60.0 % in the RSCL group
(Table 2). In the risk-adjusted analyses for the non-RSCL
group, presence of severe sepsis / septic shock was inde-
pendently related to higher mortality rates, with an ad-
justed odds ratio for death of 12.3 (Table 4). In contrast,
in the RSCL group, severe sepsis / septic shock was not
independently predictive of increased risk of death
(Table 5).
Collectively, our study suggests that emergency opera-
tive patients with severe sepsis / septic shock may bene-
fit from a staged, abbreviated laparotomy, and may have
an increased risk of death with an unstaged operative
approach. Furthermore, in the non-RSCL cohort, 44.4 %
of all patients who required unplanned re-explorations
had severe sepsis / septic shock preoperatively, compared
to only 11.9 % in the patients who were successfully
unstaged. These data also document that nearly 50 % of
patients with severe sepsis/septic shock undergoing lapar-
otomy with primary fascial closure will require re-
exploration (known as an on-demand re-laparotomy).
Similar patterns exist in the data for males and the
elderly; these inherent patient traits independently and
significantly increased the risk of mortality in emergent
non-RSCL, but were not significantly related to mortal-
ity in the RSCL cohort (Tables 4 & 5). As such, men and
those over the age of 70 may have poorer outcomes
when they undergo unstaged, non-RSCL at the time of
initial operation. Another inherent patient trait, multiple
comorbidities, was independently associated with im-
proved survival for both the non-RSCL and RSCL
groups (Tables 4 & 5). Taken together, these data indi-
cated that the elderly (≥70), males, and patients with
multiple comorbidities (≥3) may see lower odds of mor-
tality with RSCL emergent operations.
Acidosis (pH ≤ 7.25) and elevations in lactate (≥3)
often occur in concert with each other, but presence of
one does not necessarily mean presence of the other.
We therefore modeled these variables independently
from one another, as there was not a significant
interaction between these variables in our analyses. In the
RSCL group, elevated lactate independently improved
chances of survival in patients undergoing abbreviated
laparotomies; lactate was not significantly predictive of
survival benefit in the non-RSCL cohort. Patients with
acidosis (pH ≤ 7.25), on the other hand, have a very poor
prognosis across all emergent operations (Table 2). Acid-
osis was the one variable associated with poor outcomes
in both the non-RSCL and RSCL groups (Tables 4 & 5).
Because odds of mortality go up significantly and inde-
pendently with acidosis, and because survival is 50 % in
acidotic patients, we have included it as an indication for
RSCL.
The data further confirm that certain emergency pa-
tients will not benefit from RSCL, and in fact could be
harmed by undergoing abbreviated operations. Specific-
ally, patients without physiologic evidence of preopera-
tive inflammation, as defined by the SIRS criteria,
should not be considered candidates for RSLC. This co-
hort can, in most scenarios, safely undergo a non-staged
operation; this is akin to the principle of on-demand re-
laparotomy [17].
This study has limitations. First, our conclusions are
drawn from retrospective data, and are thus constrained
by the limitations and biases therein, including selection
bias. Second, the definition of an emergency patient is a
construct of the study, as well as the individual assess-
ments of the attending surgeon and anesthesiologist.
Therefore, generalizing to all emergency surgical pa-
tients may not be valid, as definitions of “emergency pa-
tient” are not standardized [31]. Thirdly, the data are
from one institution, which is a tertiary medical center
and large academic hospital; this may not be representa-
tive of a national sample from which to make conclu-
sions. Fourth, our conclusions are drawn from a small
sample size of 215 patients; we therefore lack the neces-
sary power to show potentially significant differences.
And finally, there may be other peri-operative risk fac-
tors and physiologic variables not identified here which
more accurately predict the need for RSCL in EGS
patients.
Conclusions
In conclusion, when correctly applied, the staged RSCL
may help to improve survival in decompensated EGS pa-
tients. The best candidates for staged RSCL are those
patients with severe sepsis / septic shock, who are also
male, over age 70 years old, with multiple comorbidities,
and have an elevated lactate with acidosis. Use of the
staged RSCL can also avoid unplanned re-explorations,
which occurred in nearly 50 % patients with severe sep-
sis / septic shock who underwent primary fascial closure
at the initial operation. Patients without evidence of pre-
operative inflammation may not benefit from staged
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RSCL. These results further reinforce the concept that
EGS patients represent a unique patient-population, and
that operative decision-making in these patients should
be guided by EGS-specific preoperative and intraopera-
tive physiologic metrics and variables.
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